Authorization

A new DNA test that lets you see your risk of diseases like cancer could compete with 23andMe a?? herea??s how it differs

A new DNA test that lets you see your risk of diseases like cancer could compete with 23andMe a?? herea??s how it differs
Hollis Johnson



On Tuesday, DNA testing startup Helix launched a new test that looks at your risk of diseases like breast cancer, colon cancer, and high cholesterol.




You can buy the test online for $260, but it must be approved by a physician.




Helix partnered with clinical diagnostics company PerkinElmer to create the test, which includes genetics counseling.




The test also uses a type of sequencing that some experts say all DNA-based health tests should use.



A genetics testing company you may not have heard of just made a big debut. The startup, called Helix, launched a new DNA test on Tuesday that offers some of the same health insights as those of competing tests like 23andMe, only in a format that the company claims is more comprehensive, more convenient, and more responsible.
Available online, the test looks at the impact of several dozen genetic variants on your risk of diseases such as breast cancer, colon cancer, and high cholesterol.
Called GenePrism, the new test is the result of a year-long collaboration between Helix and clinical diagnostics company PerkinElmer.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2019    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
2930